Patents by Inventor Steven J. Burgess

Steven J. Burgess has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED ORTHOPOXVIRUS VECTORS
    Publication number: 20240132913
    Abstract: The disclosure relates to modified orthopoxvirus vectors, as well as methods of using the same for the treatment of various cancers. The disclosure provides modified orthopoxvirus vectors that exhibit various beneficial therapeutic activities, including enhanced oncolytic activity, spread of infection, immune evasion, tumor persistence, capacity for incorporation of exogenous DNA sequences and safety. The viruses we have discovered are also amenable to large scale manufacturing protocols.
    Type: Application
    Filed: September 4, 2023
    Publication date: April 25, 2024
    Applicants: OTTAWA HOSPITAL RESEARCH INSTITUTE, TURNSTONE BIOLOGICS CORP.
    Inventors: John C. Bell, Fabrice Le Boeuf, Michael S. Huh, Matthew Y. Tang, Adrian Pelin, Brian Andrew Keller, Caroline J. Breitbach, Michael F. Burgess, Steven H. Bernstein
  • Modified chloroquines with single ring moiety or fused ring moiety
    Patent number: 8658648
    Abstract: The disclosure provides modified chloroquine compounds having single ring or fused ring moieties. Also provided are pharmaceutical compositions comprising such compounds, methods of using such compounds to inhibit or treat diseases or conditions caused by chloroquine-resistant (CQR) and chloroquine-sensitive (CqS) malaria parasites and other CQ-susceptible microorganisms, and processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: February 25, 2014
    Assignees: DesignMedix, Inc., Portland State University
    Inventors: David H. Peyton, Steven J. Burgess, Katherine M. Liebman, Bornface Gunsaru
  • MODIFIED CHLOROQUINES WITH SINGLE RING MOIETY OR FUSED RING MOIETY
    Publication number: 20110251210
    Abstract: The disclosure provides modified chloroquine compounds having single ring or fused ring moieties. Also provided are pharmaceutical compositions comprising such compounds, methods of using such compounds to inhibit or treat diseases or conditions caused by chloroquine-resistant (CQR) and chloroquine-sensitive (CqS) malaria parasites and other CQ-susceptible microorganisms, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: December 4, 2009
    Publication date: October 13, 2011
    Applicants: PORTLAND STATE UNIVERSITY, DESIGNMEDIX, INC.
    Inventors: David H. Peyton, Steven J. Burgess, Katherine M. Liebman, Bornface Gunsaru